They work by activating GLP-1 receptors to slow down digestion, control blood sugar, and lessen appetite
Weight Loss Percentages Mounjaro/Zepbound: In major trials, people lost an average of 20% to 22% of the body weight over 72 weeks
A reasonable deficit for many people is somewhere around 15 to 25 percent below maintenance
With the right treatment, you can take control of your weight loss journey and improve your overall health and well-being
Infographic Brief 5 Placement: Regulatory Status, Evidence Gaps, and Clinician Discussion Points Title: Retatrutide Regulatory Status Map Purpose: Show why investigational status, FDA approval, compounding restrictions, and clinician discussion matter for interpreting retatrutide information
*Source